From last weeks Webinar it appears DR is holding back and has some explaining to do.
10.06. DR. ‘A very good question and look it’s important to clarify the question.’
10.10. DR. ‘AnteoX is a critical ingredient within Ultranode so any consumer evaluating Ultranode will also be evaluating AnteoX as a component of that product.’
10.20 DR. ‘First distinction I would make Mercedes has purchase Ultranode for incorporation within their testing and validation network.’
This is the frustrating part for me.
10.30. DR. ‘We understand that the AnteoX that has been PROVIDED to them is being used in an assessment of the manufacturability of their own proprietary anodes so as far as we’re aware both valuation’s are continuing well and we remain excited about the opportunity with Mercedes.’
Now we know Mercedes has been PROVIDED with free AnteoX from the Webinar. We also know that EV2 has been testing high silicon Anodes from day one. So if AnteoX is a critical ingredient for Ultranode then EV2 has been PROVIDED with AnteoX. Going off this chart EV3 has leap frogged EV2 so they must have been PROVIDED with AnteoX and you could assume EV4-EV7 have also been PROVIDED with free AnteoX. Moving away from EV’s, we have near term possibilities with Consumer Batteries and Medical Devices, so they too must have been PROVIDED with AnteoX. That’s a lot of free give always with little to no information coming forward to shareholders. There’s a strategy in there somewhere ADO directors. Let’s hope it works out before the company is on its knees.
